Hsiao Ke-Yu, Lin Hsiu-Ling, Chen Hui-Mei, Chen Cheng-Chieh
Shin Kong Wu Ho-Su Memorial Hospital, Department of Pathology and Laboratory Medicine, Taipei, Taiwan.
Landseed International Hospital, Department of Nursing, Taoyuan, Taiwan.
Int J Gynecol Cancer. 2025 Jul;35(7):101904. doi: 10.1016/j.ijgc.2025.101904. Epub 2025 Apr 28.
Self-collection methods are regarded as a strategy to promote human papillomavirus (HPV) testing for cervical cancer screening. HPV testing using urine specimens is non-invasive and could eliminate barriers such as embarrassment and discomfort. However, concerns regarding the accuracy of this method persist. Hence, the current meta-analysis aims to verify the accuracy of urine HPV nucleic acid amplification testing.
A comprehensive search was conducted in the PubMed, Embase, and Cochrane Library databases to identify studies that evaluated the performance of urine HPV nucleic acid amplification testing. The inclusion criteria were as follows: studies that evaluated the diagnostic accuracy of HPV testing for high-grade squamous intra-epithelial lesion or worse (HSIL+) with self-collected urine specimens. In addition, studies that provided sufficient data for conducting a meta-analysis were assessed. To ensure the rigor of the study, those using histopathology or colposcopy as the reference standard were deemed sufficiently rigorous for inclusion. The meta-analysis was conducted using the bi-variate random-effects model.
A total of 21 studies with 6603 samples were identified. The meta-analysis yielded a pooled sensitivity of 83.0% (95% CI 77.5% to 87.3%) and a pooled specificity of 51.3% (95% CI 39.2% to 63.3%) of HPV nucleic acid amplification testing with self-collected urine specimens for HSIL+. In terms of detection technology, a pooled sensitivity of 85.2% and a pooled specificity of 49.4% were obtained from the sub-group analysis of manuscripts that used DNA-based testing.
Our meta-analysis indicates that urine HPV nucleic acid amplification testing achieves high sensitivity for detecting HSIL+. A notable benefit of DNA-based urine HPV nucleic acid amplification testing is its heightened sensitivity compared with RNA-based methods.
自我采集方法被视为促进人乳头瘤病毒(HPV)检测用于宫颈癌筛查的一种策略。使用尿液样本进行HPV检测是非侵入性的,并且可以消除诸如尴尬和不适等障碍。然而,对于该方法准确性的担忧依然存在。因此,当前的荟萃分析旨在验证尿液HPV核酸扩增检测的准确性。
在PubMed、Embase和Cochrane图书馆数据库中进行全面检索,以识别评估尿液HPV核酸扩增检测性能的研究。纳入标准如下:评估使用自我采集的尿液样本进行HPV检测对高级别鳞状上皮内病变或更严重病变(HSIL+)的诊断准确性的研究。此外,对提供足够数据以进行荟萃分析的研究进行评估。为确保研究的严谨性,将使用组织病理学或阴道镜检查作为参考标准的研究视为足够严谨而纳入。使用双变量随机效应模型进行荟萃分析。
共识别出21项研究,包含6603个样本。荟萃分析得出,对于HSIL+,使用自我采集的尿液样本进行HPV核酸扩增检测的合并敏感性为83.0%(95%置信区间77.5%至87.3%),合并特异性为51.3%(95%置信区间39.2%至63.3%)。在检测技术方面,从使用基于DNA检测的手稿亚组分析中获得的合并敏感性为85.2%,合并特异性为49.4%。
我们的荟萃分析表明,尿液HPV核酸扩增检测在检测HSIL+方面具有高敏感性。基于DNA的尿液HPV核酸扩增检测的一个显著优点是与基于RNA的方法相比,其敏感性更高。